Herbas VPB

Print
EN | LT
Supplementary protection
LT - Rapamicino darinys, skirtas kieto naviko, susijusio su nereguliuojama angiogeneze, gydymui
EN - RAPAMYCIN DERIVATIVE FOR THE TREATMENT OF A SOLID TUMOR ASSOCIATED WITH DEREGULATED ANGIOGENESIS
SPC
(11) Number of the document
(68) Number of the document 3351246
(21) Application number for Supplementary Protection Certificate PA 2019 521
(22) Date of filing the application 2019-11-21
(41) Date of publication of the application 2019-12-10
Date of publication of SPC
(24) Date of coming into effect of SPC
Applicant
(71) Novartis Pharma AG, Lichtstrasse 35, 4056 Basel, CH
Novartis International Pharmaceutical AG, Lichtstrasse 35, 4056 Basel, CH
Grantee
(73) Novartis Pharma AG, Lichtstrasse 35, 4056 Basel, CH
Novartis International Pharmaceutical AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/09/538/001-008, 2012-07-23
Name of the product protected by the basic patent
(95) Everolimuzas
Legal status
SPC application withdrawn
Last update date 2021-11-25